US Acquisition For Nestlé Health Science
Nestlé Health Science, a fully owned subsidiary of Nestlé, has agreed to acquire the business of Pamlab, a US-based company with an innovative portfolio of medical food products for use under medical supervision in the nutritional management of patients with mild cognitive impairment, depression and diabetic peripheral neuropathy.
The acquisition further strengthens Nestlé Health Science’s capacity to deliver personalised healthcare to address chronic medical conditions through nutrition, especially in the areas of metabolic health and brain health.
“The acquisition of the Pamlab business is aligned with our strategic ambition to provide science-based nutritional solutions for people with chronic medical conditions. Pamlab will particularly strengthen our brain health platform and provide us an additional foothold in metabolic health in the US,” says Luis Cantarell, Nestlé Health Science President and Chief Executive Officer.
